The helpful, and regularly updated, summary of new (upcoming) drugs to watch from Forbes.com.
Article discussing the ongoing battle about the use of presecribing data by pharma companies.
What do you think of “nano-learning“?
A new company to keep an eye on (OK, we have to be self-serving sometimes!).
Just for fun: if you like to see the final destination of buildings and other structures that have outlived their usefulness, this is the successful demolition of Seattle’s former Kingdome – and here’s an effort with a surprise ending!